{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:14:39Z","timestamp":1790644479970,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nrjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition Research"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.nutres.2014.04.012","type":"journal-article","created":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T03:00:25Z","timestamp":1398308425000},"page":"478-485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Serum soluble receptor for advanced glycation end products correlates inversely with measures of adiposity in young adults"],"prefix":"10.1016","volume":"34","author":[{"given":"Kathleen E.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parakat","family":"Vijayagopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanil","family":"Juma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victorine","family":"Imrhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nutres.2014.04.012_bb0005","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1001\/jama.284.13.1650","article-title":"The continuing epidemic of obesity in the United States","volume":"284","author":"Mokdad","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.nutres.2014.04.012_bb0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2337\/diacare.24.4.683","article-title":"Cardiovascular morbidity and mortality associated with the metabolic syndrome","volume":"24","author":"Isomaa","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nutres.2014.04.012_bb0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/ajcn.81.2.341","article-title":"Origins and evolution of the Western diet: health implications for the 21st century","volume":"81","author":"Cordain","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nutres.2014.04.012_bb0020","first-page":"4","article-title":"Recent advances in the relationship between obesity, inflammation and insulin resistance","volume":"17","author":"Bastard","year":"2006","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.nutres.2014.04.012_bb0025","doi-asserted-by":"crossref","first-page":"16R","DOI":"10.1093\/glycob\/cwi053","article-title":"Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation","volume":"15","author":"Ramasamy","year":"2005","journal-title":"Glycobiology"},{"issue":"S1","key":"10.1016\/j.nutres.2014.04.012_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/10715762.2013.815348","article-title":"Advanced glycation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation","volume":"47","author":"Vistoli","year":"2013","journal-title":"Free Radic Res"},{"key":"10.1016\/j.nutres.2014.04.012_bb0035","doi-asserted-by":"crossref","first-page":"17453","DOI":"10.1074\/jbc.272.28.17473","article-title":"Carboboxyethylethanolamine, a biomarker of phospholipid modification during the Maillard reaction in vivo","volume":"272","author":"Requena","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nutres.2014.04.012_bb0040","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1073\/pnas.94.12.6474","article-title":"Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy","volume":"94","author":"Koschinsky","year":"1997","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.nutres.2014.04.012_bb0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF03402014","article-title":"Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction","volume":"8","author":"Cai","year":"2002","journal-title":"Mol Med"},{"key":"10.1016\/j.nutres.2014.04.012_bb0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2796.2002.00932.x","article-title":"Diabetes and advanced glycation end products","volume":"251","author":"Vlassara","year":"2002","journal-title":"J Intern Med"},{"key":"10.1016\/j.nutres.2014.04.012_bb0055","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1196\/annals.1333.052","article-title":"Diet-derived advanced glycation end products are major contributors to the body\u2019s AGE pool and induce inflammation in healthy subjects","volume":"1043","author":"Uribarri","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nutres.2014.04.012_bb0060","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jada.2010.03.018","article-title":"Advanced glycation end products in foods and a practical guide to their reduction in the diet","volume":"110","author":"Uribarri","year":"2010","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.nutres.2014.04.012_bb0065","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jada.2004.05.214","article-title":"Advanced glycoxidation end products in commonly consumed foods","volume":"104","author":"Goldberg","year":"2004","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.nutres.2014.04.012_bb0070","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.2337\/diabetes.54.8.2314","article-title":"Insulin resistance and type 2 diabetes in high-fat fed mice are linked to high glycotoxin intake","volume":"54","author":"Sandu","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.nutres.2014.04.012_bb0075","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/ajcn\/85.5.1236","article-title":"Effects of low and high advanced glycation end product meals on macro and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus","volume":"85","author":"Negrean","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.nutres.2014.04.012_bb0080","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1196\/annals.1433.042","article-title":"Dietary advanced glycation end products and oxidative stress","volume":"1126","author":"Stirban","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nutres.2014.04.012_bb0085","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/gerona\/62.4.427","article-title":"Circulating glycotoxins and dietary advanced glycation end-products: two links to inflammatory response, oxidative stress, and gaining","volume":"62","author":"Uribarri","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.nutres.2014.04.012_bb0090","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.semnephrol.2009.07.013","article-title":"Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management or prevention of reduced renal function in elderly persons","volume":"29","author":"Vlassara","year":"2009","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.nutres.2014.04.012_bb0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2337\/diacare.27.1.223","article-title":"Association between acute-phase reactants and advanced glycation end products in type 2 diabetes","volume":"27","author":"Tan","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nutres.2014.04.012_bb0105","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2337\/dc10-1058","article-title":"Maternally transmitted and food-derived glycotoxins: a factor in preconditioning the young to diabetes?","volume":"33","author":"Mericq","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nutres.2014.04.012_bb0110","doi-asserted-by":"crossref","first-page":"15888","DOI":"10.1073\/pnas.1205847109","article-title":"Oral advanced glycation end products promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1","volume":"109","author":"Cai","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nutres.2014.04.012_bb0115","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/mnfr.200600304","article-title":"Evidence against dietary advanced glycation end products being a risk to human health","volume":"51","author":"Ames","year":"2007","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.nutres.2014.04.012_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ejcn.2011.139","article-title":"Urinary carboxymethyl-lysine, a major advanced glycation end product in adults: the Energetics Study","volume":"66","author":"Semba","year":"2012","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.nutres.2014.04.012_bb0125","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.atherosclerosis.2007.06.003","article-title":"Markers of endothelial activity are related to components of the metabolic syndrome but not to circulating concentrations of the advanced glycation end product Ne carboxymethyl lysine in healthy Swedish men","volume":"195","author":"Sjogren","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.nutres.2014.04.012_bb0130","doi-asserted-by":"crossref","first-page":"E1369","DOI":"10.1210\/jc.2013-1068","article-title":"Plasma levels of advanced glycation end products N-E(carboxymethyl)lysine, N-E(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies","volume":"98","author":"Hanssen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nutres.2014.04.012_bb0135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.fct.2013.06.052","article-title":"Advanced glycation end products in food and their effects on health","volume":"60","author":"Poulsen","year":"2013","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.nutres.2014.04.012_bb0095","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ki.2011.57","article-title":"Targeted reduction of advanced glycation improves renal function in obesity","volume":"80","author":"Harcourt","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.nutres.2014.04.012_bb0140","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1096\/fj.08-109033","article-title":"A soluble form of the receptor for advanced glycation end products (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)","volume":"22","author":"Raucci","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.nutres.2014.04.012_bb0145","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.2741\/3884","article-title":"Alternative splicing of RAGE: roles in biology and disease","volume":"16","author":"Kalea","year":"2011","journal-title":"Front Biosci"},{"key":"10.1016\/j.nutres.2014.04.012_bb0150","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.ATV.0000164804.05324.8b","article-title":"Soluble levels of receptor for advanced glycation end products (sRAGE) and coronary artery disease: the next C-reactive protein?","volume":"25","author":"Hudson","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nutres.2014.04.012_bb0155","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00726-010-0773-2","article-title":"Advanced glycation end products: from precursors to RAGE: round and round we go","volume":"42","author":"Ramasamy","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.nutres.2014.04.012_bb0160","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.tibs.2011.08.008","article-title":"RAGE: a single receptor fits multiple ligands","volume":"36","author":"Fritz","year":"2011","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.nutres.2014.04.012_bb0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/CS20100501","article-title":"RAGE biology, atherosclerosis, and diabetes","volume":"121","author":"Barlovic","year":"2011","journal-title":"Clin Sci"},{"key":"10.1016\/j.nutres.2014.04.012_bb0170","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1042\/bj20021371","article-title":"Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes and their putative roles in diabetes-induced vascular injury","volume":"370","author":"Yonekura","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.nutres.2014.04.012_bb0175","first-page":"1","article-title":"Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes","author":"Humpert","year":"2007","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.nutres.2014.04.012_bb0180","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2007.10.047","article-title":"Association between endogenous secretory RAGE, inflammatory markers, and arterial stiffness","volume":"132","author":"Choi","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.nutres.2014.04.012_bb0185","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.2337\/db11-0291","article-title":"Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial","volume":"60","author":"Colhoun","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.nutres.2014.04.012_bb0190","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1161\/01.ATV.0000190660.32863.cd","article-title":"Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis","volume":"25","author":"Koyama","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nutres.2014.04.012_bb0195","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.2337\/db09-1509","article-title":"Higher plasma soluble receptor for advanced glycation end products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study","volume":"59","author":"Nin","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.nutres.2014.04.012_bb0200","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/rheumatology\/kep199","article-title":"Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of inflammatory diseases","volume":"48","author":"Maillard-Lefebvre","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.nutres.2014.04.012_bb0205","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.metabol.2006.05.007","article-title":"Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects","volume":"55","author":"Yamagishi","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.nutres.2014.04.012_bb0210","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.numecd.2008.03.004","article-title":"Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist\/hip ratio in the general population","volume":"19","author":"Norata","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.nutres.2014.04.012_bb0215","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2012-1473","article-title":"Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress","volume":"97","author":"Vazzana","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nutres.2014.04.012_bb0220","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/ars.2012.4525","article-title":"Could receptors for advanced glycation end products be considered cardiovascular risk markers in obese children?","volume":"17","author":"Giorgis","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.nutres.2014.04.012_bb0225","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2337\/db12-1528","article-title":"sRAGE and risk of diabetes, cardiovascular disease and death","volume":"62","author":"Selvin","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.nutres.2014.04.012_bb0230","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/01.hjh.0000177535.45785.64","article-title":"Decreased plasma levels of soluble receptor for advanced glycation end products in patients with essential hypertension","volume":"23","author":"Geroldi","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.nutres.2014.04.012_bb0235","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.atherosclerosis.2009.06.003","article-title":"Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease","volume":"207","author":"Mahajan","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.nutres.2014.04.012_bb0240","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1185\/03007995.2012.717527","article-title":"Evaluation of emerging biomarkers in cardiovascular risk stratification of hypertensive patients: a 2-year study","volume":"28","author":"Derosa","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.nutres.2014.04.012_bb0245","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1210\/jc.2012-1951","article-title":"Effects of exercise on sRAGE levels and cardiometabolic risk factors in patients with type 2 diabetes: a randomized-controlled trial","volume":"97","author":"Choi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nutres.2014.04.012_bb0250","first-page":"941","article-title":"Inverse association between circulating levels of sRAGE and coronary plaque burden","volume":"19","author":"Basta","year":"2012","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.nutres.2014.04.012_bb0255","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mvr.2011.03.003","article-title":"Protective role of adiponectin on endothelial dysfunction induced by AGEs: a clinical and experimental approach","volume":"82","author":"Del Turco","year":"2011","journal-title":"Microvasc Res"},{"key":"10.1016\/j.nutres.2014.04.012_bb0260","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/clinchem\/36.1.15","article-title":"Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints","volume":"1","author":"Warnick","year":"1990","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.nutres.2014.04.012_bb0275","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.ijcard.2013.05.013","article-title":"Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases","volume":"168","author":"Mahajan","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.nutres.2014.04.012_bb0265","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.2337\/diabetes.54.7.1914","article-title":"Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model","volume":"54","author":"Chen","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.nutres.2014.04.012_bb0270","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3945\/jn.111.143172","article-title":"Fat mass is inversely associated with serum carboxymethyl-lysine, and advanced glycation end product, in adults","volume":"141","author":"Semba","year":"2011","journal-title":"J Nutr"},{"key":"10.1016\/j.nutres.2014.04.012_bb0280","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/01.ATV.0000160342.20342.00","article-title":"Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men","volume":"25","author":"Falcone","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nutres.2014.04.012_bb0285","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5301\/jn.5000122","article-title":"Relationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular risk","volume":"26","author":"Falcone","year":"2013","journal-title":"J Nephrol"},{"key":"10.1016\/j.nutres.2014.04.012_bb0295","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1196\/annals.1433.030","article-title":"Determination of N-(Carboxymethyl) lysine in foods and related systems","volume":"1126","author":"Ames","year":"2008","journal-title":"N Y Acad Sci"}],"container-title":["Nutrition Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0271531714000694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0271531714000694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T08:52:50Z","timestamp":1597740770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0271531714000694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0271531714000694"],"URL":"https:\/\/doi.org\/10.1016\/j.nutres.2014.04.012","relation":{},"ISSN":["0271-5317"],"issn-type":[{"value":"0271-5317","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum soluble receptor for advanced glycation end products correlates inversely with measures of adiposity in young adults","name":"articletitle","label":"Article Title"},{"value":"Nutrition Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nutres.2014.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}